September 2, 2014 - ASM Provides Comments on CME and LCD

ASM commented on “Revisions to Payment Policies under the Physician Fee Schedule, Clinical Laboratory Fee Schedule, Access to Identifiable Data for the Center for Medicare and Medicaid Innovation Models & Other Revisions to Part B for CY 2015”  as published in the July 11 Federal Register.   The comments focus on proposed changes in continuing medical education (CME) and the local coverage determination (LCD) process for laboratory testing. 

Read more...

August 27, 2014 - NIH Announces National Biosafety Stewardship Month

The National Institutes of Health (NIH) announces National Biosafety Stewardship Month

Read more...

ASM Statement on Dual Use Research of Concern and Biosafety

The ASM sent a statement to ASM members on Dual Use Research of Concern and Biosafety.

Read more...

August 20, 2014 - ASM Comments to FDA on Rapid Influenza Test Classification

ASM commented on an FDA proposal to reclassify antigen based rapid influenza virus antigen detection test systems intended to detect influenza virus directly from clinical specimens.

Read more...

July 30, 2014 - Historical Background Related to Select Agents

The ASM has prepared a history related to select agents.

Read more...

TPL_asm2013_SEARCH